Is creon a biologic?

Is Creon considered a biologic drug?

No. Creon is not a biologic. Creon is a brand of pancreatic enzyme replacement therapy (PERT) containing digestive enzymes (commonly lipase, protease, and amylase) that help treat conditions where the pancreas does not make enough enzymes.

Biologics are typically large, complex molecules made in living cells (for example, monoclonal antibodies, vaccines, or cell- and gene-based therapies). Creon is an enzyme formulation, not a biologically produced therapeutic made as a biologic.

Why this matters: biologic vs. non-biologic products

Because Creon is not a biologic, it is generally not regulated and discussed in the same way as biologics (such as biosimilars). Enzyme replacement therapies like Creon are usually handled under standard small-molecule/non-biologic drug frameworks rather than the biologics pathway.

What patients usually ask next

People often ask whether Creon has a “generic” or “biosimilar.” Since it is not a biologic, the relevant issue is typically whether non-biologic equivalents/alternatives are available, not biosimilar approval.

Sources

No sources were provided in the prompt.